production and quality control of 82mrb and primary pet scans using its radiopharmaceutical for heart examinations [persian]

according to the importance of positron emitters in nuclear medicine, 82mrb was produced as a member of this group of radiopharmaceuticals. after being converted into an injectable form, enough information was provided for imaging with this radiopharmaceutical. 82mrb with high radioisotopic purity and half-life of 6.5 hours, in chloride form, can be considered as a suitable positron emitter for the assessment of myocardial function. as a result of the bombardment of 82kr with 15.4 mev protons, the activity of 35.04 mci was finally achieved. the nuclear reaction efficiency was 6.37 mci/μah. the product had a high radiopharmaceutical purity, according to international standards.